PAR 0.00% 27.5¢ paradigm biopharmaceuticals limited..

You know this trial is a double-blinded control trial right? The...

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    You know this trial is a double-blinded control trial right? The data doesn't get unlocked prior to complete patient enrolment and after the last time-point. This extension is not a reflection of "quality data" being seen. This (as they stated), is due to feedback from KOL's that twice weekly injections isn;t commercially appetising, hence they're trying once a week. IMO
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.